|
1
|
|
Monoclonal antibody CIS43LS sets the bar for long-acting malaria protection.
(jci.org)
|
Sullivan DJ
Journal of Clinical Investigation
2026-08-17
|
#malaria
#antibody
#immunotherapy
#prevention
#parasite
|
|
1
|
|
Chimeric antigen receptor (CAR) therapy in infectious diseases: emerging applications with a focus on invasive fungal infections.
(linkinghub.elsevier.com)
|
Bracke C
…
Puerta-Alcalde P
Clinical Microbiology and Infection
2026-08-17
|
#immunotherapy
#fungal infection
#immunocompromised
#car t cells
#antifungal
|
|
1
|
|
Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy.
(jci.org)
|
Lu L
…
Deng L
Journal of Clinical Investigation
2026-08-17
|
#cancer
#immunotherapy
#radiotherapy
#immunogenicity
#microenvironment
|
|
1
|
|
Caloric restriction suppresses colorectal tumors and melanoma through CD8 T cells in aged mice.
(linkinghub.elsevier.com)
|
Horino T
…
Oike Y
Cell Reports
2026-08-17
|
#cancer
#immunotherapy
#immunity
#aging
#transcriptomics
|
|
2
|
|
Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.
(nature.com)
|
Chen Y
…
Dong L
Nature Cancer
2026-08-17
|
#microbiome
#immunotherapy
#pancreatic cancer
#metabolism
#macrophage
|
|
4
|
|
Intratumoral Bacillus cereus orchestrates stem-like lymphoid niches to potentiate immunotherapy response in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Hu C
…
Chen Y
Cancer Cell
2026-08-17
|
#immunotherapy
#hepatocellular carcinoma
#microbiome
#immunity
#spatial omics
|
|
1
|
|
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.
(nature.com)
|
Jung H
…
Carnevale J
Nature Biotechnology
2026-08-17
|
#crispr
#genome editing
#screening
#immunotherapy
#macrophage
|
|
1
|
|
A VHL-HIF signaling axis orchestrates invariant natural killer T cell development and fate decisions.
(linkinghub.elsevier.com)
|
Li Q
…
Liu YC
Developmental Cell
2026-08-17
|
#immunity
#differentiation
#immunotherapy
#lymphocyte
#signaling
|
|
1
|
|
Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC.
(pnas.org)
|
Shinn CK
…
Handel TM
PNAS
2026-08-17
|
#immunotherapy
#carcinoma
#lymphocyte
#chemokines
#angiogenesis
|